Additional ongoing studies target JAK/STAT signaling with SHR-0302 and SHR-2554 (NCT06519526), as well as agents modulating the Notch (e.g., MK-0752, NCT00106145), Hippo (e.g., IK-930, NCT05228015), and GAS6/AXL (e.g., bemcentinib, NCT02424617) pathways in a variety of advanced or resistant tumors
Cellular Senescence: Inadequate glutathione accelerates cellular senescence (when cells stop dividing), contributing to aging tissues and organ dysfunction
These risks are not DSIP-specific but are relevant to all injectable peptides used outside a clinical setting
Caution & Warnings : WARNING: Do not use if under the age of 18, pregnant or nursing
Populations of particular concern based on ingredient mechanism and the absence of adequate human data include: individuals with Wilson's disease or other copper metabolism disorders
Results depend on maintenance and lifestyle